Comparable stake leader
Jorey Chernett
SEC ownership of OKYO Pharma Ltd
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001849296.
Disclosed value leader
Gabriele M. Cerrone
Comparable rows
28/32
Latest evidence
27 Jul 2026
- Public ticker
- OKYO on Nasdaq
- Parsed ownership sources
-
13D/G, 13F, and 3/4/5
Source: Parsed SEC ownership filingsUse: Compare filing families carefully
- Largest SEC-reported holder
-
Jorey Chernett
Ranking: Comparable ownership first, then disclosed value
- Comparable ownership rows
-
28 of 32
Meaning: Rows with safely comparable ownership %
- Latest 13D/G holder
-
Jorey Chernett
Source: Latest parsed Schedule 13D/G stake
- Latest parsed ownership date
-
27 Jul 2026
Freshness: Most recent filing date in this holder set
- Issuer CIK
- 0001849296
- Issuer location
- London, United Kingdom
Ownership snapshot
CIK-linked ownership evidence from parsed SEC filings.
3 signals
Issuer
Names, identifiers, and filing context for this profile.
2 identity fields
Ownership snapshot
Top shareholders of OKYO Pharma Ltd (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Jorey Chernett
Disclosed value leader
Gabriele M. Cerrone
Comparable rows
28/32
Latest evidence
27 Jul 2026
13D/G
13F
3/4/5
Lead comparable stake: 9.5%
4 rows are not safely comparable across share classes.
13D/G row: Jorey Chernett
Showing 1-8 of 32 holder rows.
Quick read
Jorey Chernett leads the comparable SEC ownership view at 9.5%.
28 of 32 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Jorey Chernett's linked filing trail.
Comparable ownership
Top 5
Jorey Chernett
9.5%
Sirenia Capital Management LP
7.7%
Woodline Partners LP
7%
Laura Natalia Monica Fonda
5%
Dauntless Investment Group, LLC
1.2%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-8 of 32 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Jorey Chernett |
13D/G
Chernett Jorey
|
9.5%
|
$11,824,823
3,802,194 shares
|
+$2,541,903 | 31 Dec 2025 |
| Sirenia Capital Management LP |
13D/G
|
7.7%
|
$6,202,703
4,054,054 shares
|
$0 | 31 Mar 2026 |
| Woodline Partners LP |
13D/G
13F
Company
|
7%
|
$5,587,851
3,652,190 shares
|
$0 | 31 Mar 2026 |
| Laura Natalia Monica Fonda |
13D/G
|
5%
|
$3,856,902
1,928,451 shares
|
$0 | 22 Jul 2025 |
| Dauntless Investment Group, LLC |
13D/G
|
1.2%
|
$1,466,437
471,523 shares
|
-$6,066,133 | 31 Dec 2025 |
| Gabriele M. Cerrone |
3/4/5
Director, 10%+ Owner
|
41%
|
$33,662,085
21,400,332 shares
|
+$67,625 | 21 Jul 2026 |
| Gary S. Jacob |
3/4/5
CHIEF DEVELOPMENT OFFICER, Director
|
0.22%
|
$157,388
112,420 shares
|
+$4,900 | 21 Jul 2026 |
| Rajkumar Patil V |
3/4/5
Chief Scientific Officer
|
0.04%
|
$29,844
20,030 shares
|
+$5,011 | 27 Jul 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Net insider flow leans to buying over the last 12 months. Net value: +$136,006.
Buys
$136,006
Insiders: 6
Sells
$0
Insiders: 0
Net
+$136,006
Shares: +94,363
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 94,363
Shares: 0
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 94,363 | 0 | $136,006 | $0 | +$136,006 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-10 of 10 reporting-owner rows connected to OKYO Pharma Ltd. Open a relationship link for the CIK-to-CIK filing trail.
Rows
10
Largest Forms 3/4/5 holder
Gabriele M. Cerrone
Net 12M change
+$136,006
Latest report
27 Jul 2026
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Gabriele M. Cerrone | Director, 10%+ Owner | $33,662,085 | +$67,625 | +0.2% | Mixed | 21 Jul 2026 |
| Gary S. Jacob | CHIEF DEVELOPMENT OFFICER, Director | $157,388 | +$4,900 | +3.2% | Filing P/S | 21 Jul 2026 |
| John P. Brancaccio | Director | $51,991 | +$7,385 | +17% | Filing P/S | 21 Jul 2026 |
| Rajkumar Patil V | Chief Scientific Officer | $29,844 | +$5,011 | +20% | Filing P/S | 27 Jul 2026 |
| Flavio Mantelli | Chief Medical Officer | $28,000 | +$28,000 | +100% | Filing P/S | 21 Jul 2026 |
| Keeren Rameshchandra Shah | Chief Financial Officer | $26,333 | Mixed | 08 Jun 2026 | ||
| Willy Jules Simon | Director | $25,535 | Mixed | 08 Jun 2026 | ||
| Robert John Dempsey | CHIEF EXECUTIVE OFFICER, Director | $23,085 | +$23,085 | +100% | Filing P/S | 22 Jul 2026 |
| Bernard Denoyer | Director | Mixed | 08 Jun 2026 | |||
| Keeren Shah | Chief Financial Officer | Mixed | 16 May 2022 |
Recent insider transactions for OKYO Pharma Ltd
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Rajkumar Patil V | OKYO | COMMON STOCK | Purchase | 20.2% | $5,011 | $1.49 | 3,363 | 20,030 | 27 Jul 2026 | Direct |
| Robert John Dempsey | OKYO | COMMON STOCK | Purchase | $23,085 | $1.54 | 15,000 | 15,000 | 22 Jul 2026 | Direct | |
| John P. Brancaccio | OKYO | COMMON STOCK | Purchase | 16.6% | $7,385 | $1.48 | 5,000 | 35,201 | 21 Jul 2026 | Direct |
| Gary S. Jacob | OKYO | COMMON STOCK | Purchase | 3.21% | $4,900 | $1.40 | 3,500 | 112,420 | 21 Jul 2026 | Direct |
| Gabriele M. Cerrone | OKYO | COMMON STOCK | Purchase | 0.21% | $32,625 | $1.45 | 22,500 | 10,873,916 | 21 Jul 2026 | Via Panetta Partners Limited |
| Flavio Mantelli | OKYO | COMMON STOCK | Purchase | $28,000 | $1.40 | 20,000 | 20,000 | 21 Jul 2026 | Direct | |
| Gabriele M. Cerrone | OKYO | COMMON STOCK | Purchase | 0.23% | $35,000 | $1.40 | 25,000 | 10,851,416 | 20 Jul 2026 | Via Panetta Partners Limited |
| Bernard Denoyer | OKYO | Option | Award | 11% | 3,500 | 35,190 | 08 Jun 2026 | Direct | ||
| John P. Brancaccio | OKYO | Option | Award | 4.93% | 6,500 | 138,394 | 08 Jun 2026 | Direct | ||
| Willy Jules Simon | OKYO | Option | Award | 5.04% | 6,500 | 135,502 | 08 Jun 2026 | Direct | ||
| Keeren Rameshchandra Shah | OKYO | Option | Award | 7.92% | 40,000 | 544,819 | 08 Jun 2026 | Direct | ||
| Gabriele M. Cerrone | OKYO | COMMON STOCK | Award | 2.85% | 300,000 | 10,826,416 | 08 Jun 2026 | Via Panetta Partners Limited |
* marks a reported price that did not pass the local price check.